Latest News

Come learn about Novela’s unique Open Source Wireless Neuromodulation Research Kit at UHN's CRANIA Industry Partnership Day

February 12, 2020 /in Latest News

CRANIA, Novela Neurotech and Hahn Schickard join hands to accelerate the translation of Novela’s neuromodulation research kit

TORONTO, ON — February, 2020 – CRANIACenteR for Advancing Neurotechnological Innovation to Application, a world-class centre for R&D, application and commercialization of neuromodulation innovations and interventions, championed by the University Health Network (UHN), Canada’s largest research hospital, and the...

Read More

UHN Spin-off Bridge7 Oncology Wins Prestigious FACIT's Falcons' Fortunes Pitch Competition

February 06, 2020 /in Latest News

FACIT announces Artificial Intelligence pitch as Winner of 2020 Falcons' Fortunes on World Cancer Day

Annual cancer-focused pitch competition showcases Ontario's emerging entrepreneurs and FACIT's commitment to drive local value from intellectual property

TORONTO, ON (February 5, 2020) – In front of another at-capacity, packed house of scientists, innovation experts and community stakeholders, FACIT crowned the newest winner of its annual Falcons’ Fortunes pitch competition. The winning pitch was delivered by Mr. Meir Dick of Bridge7 Oncology. This local start-up is scaling clinical expertise with AI to automate and improve the efficiency,...

Read More

UHN, Canada’s largest research hospital, launches another company based on drugs discovered and developed at Princess Margaret

January 14, 2020 /in Latest News

TIO Bioventures Launches Treadwell Therapeutics, Seeded With $27m to Develop First-in-Class Oral Medicines Against Novel Targets

Industry Veteran Rachel W. Humphrey, M.D., Head of R&D at TIO Discovery, appointed as Board Member and Chief Medical Officer of Treadwell Therapeutics

January 13, 2020 08:05 AM Eastern Standard Time

NEW YORK--(BUSINESS WIRE)--TIO Bioventures, an emerging life science venture creation fund with a mission to build companies with innovative anti-cancer therapies, today announced the launch of Treadwell Therapeutics, a clinical-stage oncology company exploiting cancer cells’ vulnerabilities to develop first-in-class and best-in-class small molecules to address unmet needs in patients with cancer. Treadwell, one of TIO Bioventures family...

Read More

TDC is Hiring! Administrative Assistant II, Research Agreement & Finance Support

January 10, 2020 /in Latest News

Join TDC! The Administrative Assistant II, Research Agreement & Finance Support, will have an important role in TDC operations, ensuring that the numerous Material Transfer Agreements (MTAs),certain other agreements, as well as invoices and revenue distributions which pass in and out of UHN are processed quickly, accurately, and documented appropriately. 

See full details and apply online HERE

 

 

Behind the Breakthrough Podcast Episode 11 - Beating back Alzheimer’s, one poem at a time, with Dr. Donald Weaver

December 17, 2019 /in Latest News

Air Date: December 17, 2019 | Length: 37:14

In the final episode of Behind the Breakthrough, we hear from Dr. Donald Weaver, director of the Krembil Research Institute. Dr. Weaver talks about his groundbreaking research into Alzheimer’s disease, and explains how drug research works and the challenges of getting to a clinical trial. He also tells us why his response to questions of “What next?” is a cheery “More failure!,” the purpose of his weekly story-telling in team meetings, and talks about his poetry career.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 9 - Pioneering research by UHN’s Dr. Kristin Musselman is designed to get spinal cord injured patients mobile

December 06, 2019 /in Latest News

Air Date: December 3, 2019 | Length: 30:22

Dr. Kristin Musselman is a pioneer in research designed to get patients with partial spinal cord injury up and walking again. She joins UHN’s Behind the Breakthrough podcast to talk about her latest research, how it relies heavily on patient input, and the satisfaction of seeing those same patients try new strategies to regain mobility and maintain their balance.

Get this episode:​

...

Read More

UHN Spin-off MolecuLight Receives FDA 510(k) Clearance for its i:X® Handheld Fluorescence Imaging Device for Wound Management

December 05, 2019 /in Latest News

New FDA Approval Extends Label to Including the i:X’s Detection of Bacteria and Digital Wound Measurement

TORONTO, Canada – (December 5, 2019) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time visualization of fluorescence in wounds, has received FDA 510(k) clearance for its i:X® handheld fluorescence imaging device for use in the detection of wounds containing bacteria. This FDA 510(k) clearance is an expansion of the original de novo clearance for the MolecuLight i:X platform, granted on August 14, 2018. The MolecuLight i:X enables real time point-of-...

Read More

Behind the Breakthrough Podcast Episode 8 - Reversing blindness and the serendipity of science, with Dr. Valerie Wallace

December 02, 2019 /in Latest News

Air Date: November 26, 2019 | Length: 35:04

Dr. Valerie Wallace is on a mission to reverse blindness. The award-winning senior scientist and co-director of the Donald K. Johnson Eye Institute at UHN’s Krembil Research Institute sits down with Behind the Breakthrough to discuss the serendipity of science, the curiosity that drives her and the changing landscape of women in STEM.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 7 – Repairing broken hearts with stem cells, with Dr. Michael Laflamme

December 02, 2019 /in Latest News

Air Date: November 19, 2019 | Length: 28:22

In this episode of Behind the Breakthrough, we hear from cardiac pathologist and award-winning principal investigator at the McEwen Stem Cell Institute Dr. Michael Laflamme. His mission: to restore the function of injured hearts by replacing scar tissue with healthy heart muscle cells made from stem cells.

Get this episode:​

...

Read More

TDC is Hiring! Licensing and Commercialization Professional, KITE

November 21, 2019 /in Latest News

University Health Network (UHN) is looking for an experienced professional to fill the key role of Licensing & Commercialization Professional in our Technology Development and Commercialization Department (TDC).

Learn more, and apply here

UHN Remains Canada’s Top Research Hospital!

November 18, 2019 /in Latest News

11/14/2019

Collage of UHN buildings

UHN spent $362.8 million on research activities in the last fiscal year, a 3.6 per cent increase from the previous year, to rank first on the RE$EARCH Infosource Inc. list of Canada’s Top Research Hospitals. (Graphic: UHN)

For the ninth year in a row, UHN tops RE$EARCH Infosource Inc.’s list of Canada’s Top 40 Research Hospitals. The list has been compiled annually since 2011. 

In the last fiscal year, UHN spent $362.8 million on research activities – representing 3.6 per cent more than the previous year, and approximately 17.5 per cent of its total hospital spending.  

The...

Read More

Behind the Breakthrough Podcast Episode 6 – Overcoming ‘imposter syndrome’ and helping the elderly live well, with Dr. Jennifer Campos

November 15, 2019 /in Latest News

Air Date: November 12, 2019 | Length: 40:02

Growing up, the death of Dr. Jenny Campos’ grandfather from a preventable fall while carrying groceries up a flight of stairs shook her family to the core. Today, it is the driving force behind her research in falls and driving collision prevention in the elderly. By simulating real life challenges in Toronto Rehabilitation Institute’s renowned Challenging Environment Assessment Lab (CEAL), Dr. Campos is finding ways to help older adults live well.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 5 – Meet the cancer codebreaker, Dr. Mathieu Lupien

November 15, 2019 /in Latest News

Air Date: November 5, 2019 | Length: 47:38

In the battle to defeat cancer, award-winning UHN researcher Dr. Mathieu Lupien is a modern-day version of the Bletchley Park World War Two codebreakers. Dr. Lupien searches the human genome, trying to crack the origin of how and why cancer starts. He knows deciphering that enigmatic code is one of the keys that will lead to a cure for cancer. Dr. Lupien also talks about the Terry Fox loonie he carries in his pocket at all times as a reminder of the commitment and importance of the work done in his lab, how a line in a TV show he watched as a child in Quebec has fuelled his research career,” and his advice for kids who want to go into science.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 4 – Robotics, rehabilitation therapy and learning from failure, with Dr. Milos Popovic

November 15, 2019 /in Latest News

Episode 4 – Robotics, rehabilitation therapy and learning from failure, with Dr. Milos Popovic

Air Date: October 29, 2019 | Length: 32:03

We sit down with Dr. Milos Popovic to hear about his transformational shift from aerospace engineering to rehabilitation research, and how it led to his invention of a medical device that delivers electrical stimulation to restore upper limb mobility to people with paralysis caused by spinal cord injury and stroke. Originally from Belgrade, Dr. Popovic shares how he narrowly escaped Yugoslavia’s brutal civil war as military soldiers banged on doors looking for conscripts.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 3 – Challenging the meaning of palliative care, with Dr. Camilla Zimmermann

November 15, 2019 /in Latest News

Air Date: October 22, 2019 | Length: 43:20

Dr. Camilla Zimmermann talks about how her research has helped change the practice of palliative care from end-of-life care to a more wholistic approach that answers the question, “What do you want to do with the rest of your life?” Dr. Zimmermann also reveals how the death of her parents when she was a teenager shaped her career, her initial reluctance to admit to colleagues her desire to be a palliative care specialist, and how stigma still hangs on the concept of what is palliative care.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 2 – Chronic pain and scientific baseball, with Dr. Karen Davis

November 15, 2019 /in Latest News

Air Date: October 15, 2019 | Length: 34:56

In this episode, neuroscientist Dr. Karen Davis talks to us about pain. What is it? Can we predict it? What does personality-type have to do with it? While the complexity of pain is still not well understood, the uncertainty doesn’t stop Dr. Davis and her team. “We all have doubts,” she says. “But what drives most of us is a very fundamental curiosity … and the more we interact with patients the more it motivates us to think outside the box.”

Get this episode:​

...

Read More

UHN Launches Behind the Breakthrough Podcast

October 09, 2019 /in Latest News

Behind the Breakthrough: ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ A podcast about the people behind the world-leading research at UHN

UHN Podcast Behind the Breakthrough Cover

UHN is excited to launch a new podcast series called "Behind the Breakthrough". Featuring interviews with scientists from across UHN, the podcast reveals the motivation behind their pursuit of answers to important questions—what is the cure for Alzheimer disease? How can we help prevent the elderly from falling? Will stem cells regenerate damaged hearts? How does cancer start?

Episodes present intimate, one-on-one conversations with UHN scientists...

Read More

UHN Spin-off Technology, Moleculight's i:X, is Featured at the Largest Canadian Wound Care Conference

October 07, 2019 /in Latest News

Results from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System
 Featured Prominently at the Wounds Canada 2019 Annual Conference

October 4, 2019

Point-of-Care Fluorescence Imaging for Chronic Wounds and its Significant Clinical Benefits are Featured at the Largest Canadian Wound Care Conference in 5 Clinical Talks and Posters

NIAGARA FALLS, Canada and TORONTO, Canada – (October 4, 2019) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time visualization of bacteria for chronic wounds, and its i:X point-of-care fluorescence imaging device are featured prominently at the Wounds Canada 2019 Annual Conference. The conference, which is the...

Read More

First patients treated with machine learning generated plans as part of an evaluation study at UHN's Princess Margaret Cancer Centre

September 17, 2019 /in Latest News

 

The first-ever patient radiation therapy treatments generated with machine learning in the RayStation® treatment planning system (TPS) have been conducted. Patients with localized prostate cancer are being treated with this unique technology at the Princess Margaret Cancer Centre in Toronto, Canada, as part of a comprehensive evaluation study.

RaySearch released the machine learning features in RayStation 8B* in late December 2018. This ground-breaking technology has been developed by RaySearch’s in-house machine learning department in collaboration with researchers at UHN's Princess Margaret Cancer Centre and Techna Institutes, crystalizing years of cutting-edge research led by UHN medical physicist Dr. Tom Purdie and UHN computer scientist Dr. Chris McIntosh. The features represent the first applications of machine learning in a TPS on the radiation...

Read More

UHN Research's Gordon Keller Receives Ogawa-Yamanaka Stem Cell Prize

September 05, 2019 /in Latest News

World-renowned stem cell scientist Gordon Keller, PhD, is the recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize awarded by the Gladstone Institutes for his work with pluripotent stem cells.

Dr. Keller is the Director of the McEwen Stem Cell Institute at the University Health Network, Senior Scientist at Princess Margaret Cancer Centre and Professor in the department of medical biophysics at the University of Toronto. He was recognized for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and...

Read More